Company Monitoring Page for Amarin

latest headlines for company on cafepharma

2 Biotech Stocks Poised for Big Gains in 2019
Motley Fool
Mon, 12/3/18 - 10:42 pm
Tags:
Amarin, Vascepa, Novavax, ResVax
Amarin raises $200M ahead of Vascepa push
BioCentury
Tue, 11/27/18 - 11:48 pm
Tags:
Amarin, Vascepa
Amarin's Vascepa trial stirs data debate as stock drops 10%
Biopharma Dive
Mon, 11/12/18 - 11:42 pm
Tags:
Amarin, Vascepa
Amarin's Fish-Oil-Derived Drug Shows Great Promise — With Big Caveats
Forbes
Sun, 11/11/18 - 09:19 pm
Tags:
Amarin, Vascepa
Why Amarin Stock Jumped 28% in October -- and Why a Bigger Move Could Come Soon
Motley Fool
Sun, 11/4/18 - 02:33 pm
Tags:
Amarin, Vascepa
Experts question Amarin's early touting of Vescepa data ahead of detailed results
Endpoints
Fri, 11/2/18 - 11:12 am
Tags:
Amarin, Vascepa, heart disease
[video+transcript] How Big Could Amarin's Vascepa Be?
Motley Fool
Mon, 10/1/18 - 09:54 am
Tags:
Vascepa, Amarin
3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph
Yahoo/Motley Fool
Thu, 09/27/18 - 10:07 am
Tags:
Amarin, Vascepa, Amgen, Sanofi, Regeneron
Amarin Soars as Fish Oil Pill Cuts Risk of Strokes in Long-Awaited Study
Xconomy
Mon, 09/24/18 - 09:37 am
Tags:
Amarin, fish oil, strokes, Vascepa
Why Amarin Corporation Skyrocketed 23.9% in August
Motley Fool
Tue, 09/4/18 - 09:41 am
Tags:
Amarin, Vascepa
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Tags:
Adamis, GSK, Sangamo BioSciences, Roche, Bluebird Bio, ProQR Therapeutics, Geron, Amarin, Palatin, EyeGate, Galactin, Omeros, Atossa Genetics
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Motley Fool
Mon, 09/3/18 - 12:20 pm
Tags:
Amarin, CRISPR Therapeutics, Geron, Vascepa, Vertex Pharmaceuticals, CTX001, JNJ, imetelstat
Analysts: Amarin poised for huge gains if Vascepa trial comes back positive
Medical Marketing and Media
Mon, 08/6/18 - 11:58 pm
Tags:
Amarin, Vascepa
Amarin's Vascepa goes on TV to lay groundwork for impending CV outcomes data
Fierce Pharma
Mon, 07/30/18 - 11:32 pm
Tags:
Amarin, Vascepa, physicians, television ads
Sink or swim for fish oils, and Amarin
EP Vantage
Mon, 07/16/18 - 09:58 am
Tags:
Amarin, Vascepa
Boom-or-Bust News Is On Tap Soon for Amarin
Motley Fool
Thu, 04/5/18 - 08:54 am
Tags:
Amarin, Vascepa, triglycerides
Amarin's Salyer preps for Vascepa push
Medical Marketing and Media
Tue, 12/12/17 - 10:55 pm
Tags:
Amarin, Vascepa
8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St
Sat, 09/3/16 - 12:17 pm
Tags:
FDA, Achillion, odalasvir, AL-335, simeprevir, Amarin, Vascepa, Array Biopharma, binimetinib, Mast Therapeutics, vepoloxamer, Novavax, Threshold Pharmaceuticals, tarloxotinib
Amarin slips after adding second interim efficacy trial to PhIII CV trial
Fierce Biotech
Thu, 08/4/16 - 09:13 pm
Tags:
Amarin, clinical trials, Vascepa
This Tiny Biopharma Has Been Bucking The Downtrend
Motley Fool
Mon, 06/27/16 - 03:04 pm
Tags:
Amarin, Vascepa

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.